-
1
-
-
0025045928
-
Dexmedetomidine, an alpha 2-adrenoceptor agonist, reduces anesthetic requirements for patients undergoing minor gynecologic surgery
-
Aantaa R, Kanto J, Scheinin M, Kallio A, Scheinin H. Dexmedetomidine, an alpha 2-adrenoceptor agonist, reduces anesthetic requirements for patients undergoing minor gynecologic surgery. Anesthesiology 1990; 73: 230-5.
-
(1990)
Anesthesiology
, vol.73
, pp. 230-235
-
-
Aantaa, R.1
Kanto, J.2
Scheinin, M.3
Kallio, A.4
Scheinin, H.5
-
2
-
-
55149101973
-
Effects of dexmedetomidine on propofol and remifentanil infusion rates during total intravenous anesthesia for spine surgery in adolescents
-
Ngwenyama NE, Anderson J, Hoernschemeyer DG, Tobias JD. Effects of dexmedetomidine on propofol and remifentanil infusion rates during total intravenous anesthesia for spine surgery in adolescents. Paediatr Anaesth 2008; 18: 1190-5.
-
(2008)
Paediatr Anaesth
, vol.18
, pp. 1190-1195
-
-
Ngwenyama, N.E.1
Anderson, J.2
Hoernschemeyer, D.G.3
Tobias, J.D.4
-
3
-
-
0035137056
-
Effect of dexmedetomidine on propofol requirements in healthy subjects
-
Dutta S, Karol MD, Cohen T, Jones RM, Mant T. Effect of dexmedetomidine on propofol requirements in healthy subjects. J Pharm Sci 2001; 90: 172-81.
-
(2001)
J Pharm Sci
, vol.90
, pp. 172-181
-
-
Dutta, S.1
Karol, M.D.2
Cohen, T.3
Jones, R.M.4
Mant, T.5
-
4
-
-
0032855010
-
Effects of dexmedetomidine on isoflurane requirements in healthy volunteers. 1: Pharmacodynamic and pharmacokinetic interactions
-
Khan ZP, Munday IT, Jones RM, Thornton C, Mant TG, Amin D. Effects of dexmedetomidine on isoflurane requirements in healthy volunteers. 1: Pharmacodynamic and pharmacokinetic interactions. Br J Anaesth 1999; 83: 372-80.
-
(1999)
Br J Anaesth
, vol.83
, pp. 372-380
-
-
Khan, Z.P.1
Munday, I.T.2
Jones, R.M.3
Thornton, C.4
Mant, T.G.5
Amin, D.6
-
5
-
-
84984559482
-
Opioid consumption in total intravenous anesthesia is reduced with dexmedetomidine: A comparative study with remifentanil in gynecologic videolaparoscopic surgery
-
Bulow NM, Barbosa NV, Rocha JB. Opioid consumption in total intravenous anesthesia is reduced with dexmedetomidine: a comparative study with remifentanil in gynecologic videolaparoscopic surgery. J Clin Anesth 2007; 19: 280-5.
-
(2007)
J Clin Anesth
, vol.19
, pp. 280-285
-
-
Bulow, N.M.1
Barbosa, N.V.2
Rocha, J.B.3
-
6
-
-
0031442021
-
Propofol anesthesia and rational opioid selection: Determination of optimal EC50-EC95 propofol-opioid concentrations that assure adequate anesthesia and a rapid return of consciousness
-
Vuyk J, Mertens MJ, Olofsen E, Burm AG, Bovill JG. Propofol anesthesia and rational opioid selection: determination of optimal EC50-EC95 propofol-opioid concentrations that assure adequate anesthesia and a rapid return of consciousness. Anesthesiology 1997; 87: 1549-62.
-
(1997)
Anesthesiology
, vol.87
, pp. 1549-1562
-
-
Vuyk, J.1
Mertens, M.J.2
Olofsen, E.3
Burm, A.G.4
Bovill, J.G.5
-
7
-
-
0027440617
-
Preliminary pharmacokinetics and pharmacodynamics of an ultra-short-acting opioid: Remifentanil (GI87084B)
-
Glass PS, Hardman D, Kamiyama Y, Quill TJ, Marton G, Donn KH, et al. Preliminary pharmacokinetics and pharmacodynamics of an ultra-short-acting opioid: remifentanil (GI87084B). Anesth Analg 1993; 77: 1031-40.
-
(1993)
Anesth Analg
, vol.77
, pp. 1031-1040
-
-
Glass, P.S.1
Hardman, D.2
Kamiyama, Y.3
Quill, T.J.4
Marton, G.5
Donn, K.H.6
-
8
-
-
0027375940
-
Pharmacokinetics of remifentanil (GI87084B) and its major metabolite (GI90291) in patients undergoing elective inpatient surgery
-
Westmoreland CL, Hoke JF, Sebel PS, Hug CC Jr, Muir KT. Pharmacokinetics of remifentanil (GI87084B) and its major metabolite (GI90291) in patients undergoing elective inpatient surgery. Anesthesiology 1993; 79: 893-903.
-
(1993)
Anesthesiology
, vol.79
, pp. 893-903
-
-
Westmoreland, C.L.1
Hoke, J.F.2
Sebel, P.S.3
Hug Jr., C.C.4
Muir, K.T.5
-
9
-
-
0033860761
-
The effects of increasing plasma concentrations of dexmedetomidine in humans
-
Ebert TJ, Hall JE, Barney JA, Uhrich TD, Colinco MD. The effects of increasing plasma concentrations of dexmedetomidine in humans. Anesthesiology 2000; 93: 382-94.
-
(2000)
Anesthesiology
, vol.93
, pp. 382-394
-
-
Ebert, T.J.1
Hall, J.E.2
Barney, J.A.3
Uhrich, T.D.4
Colinco, M.D.5
-
10
-
-
0026677968
-
Effects of intravenous dexmedetomidine in humans: II. hemodynamic changes
-
Bloor BC, Ward DS, Belleville JP, Maze M. Effects of intravenous dexmedetomidine in humans: II. hemodynamic changes. Anesthesiology 1992; 77: 1134-42.
-
(1992)
Anesthesiology
, vol.77
, pp. 1134-1142
-
-
Bloor, B.C.1
Ward, D.S.2
Belleville, J.P.3
Maze, M.4
-
11
-
-
44649125433
-
Dexmedetomidine infusion during laparoscopic bariatric surgery: The effect on recovery outcome variables
-
Tufanogullari B, White PF, Peixoto MP, Kianpour D, Lacour T, Griffin J, et al. Dexmedetomidine infusion during laparoscopic bariatric surgery: the effect on recovery outcome variables. Anesth Analg 2008; 106: 1741-8.
-
(2008)
Anesth Analg
, vol.106
, pp. 1741-1748
-
-
Tufanogullari, B.1
White, P.F.2
Peixoto, M.P.3
Kianpour, D.4
Lacour, T.5
Griffin, J.6
-
12
-
-
0033623230
-
Clinical uses of alpha2-adrenergic agonists
-
Kamibayashi T, Maze M. Clinical uses of alpha2-adrenergic agonists. Anesthesiology 2000; 93: 1345-9.
-
(2000)
Anesthesiology
, vol.93
, pp. 1345-1349
-
-
Kamibayashi, T.1
Maze, M.2
-
13
-
-
0023903938
-
Characterization of the selectivity, specificity and potency of medetomidine as an [alpha]2-adrenoceptor agonist
-
Virtanen R, Savola JM, Saano V, Nyman L. Characterization of the selectivity, specificity and potency of medetomidine as an [alpha]2-adrenoceptor agonist. Eur J Pharmacol 1988; 150: 9-14.
-
(1988)
Eur J Pharmacol
, vol.150
, pp. 9-14
-
-
Virtanen, R.1
Savola, J.M.2
Saano, V.3
Nyman, L.4
-
15
-
-
58149289642
-
Recovery profiles from dexmedetomidine as a general anesthetic adjuvant in patients undergoing lower abdominal surgery
-
Ohtani N, Kida K, Shoji K, Yasui Y, Masaki E. Recovery profiles from dexmedetomidine as a general anesthetic adjuvant in patients undergoing lower abdominal surgery. Anesth Analg 2008; 107: 1871-4.
-
(2008)
Anesth Analg
, vol.107
, pp. 1871-1874
-
-
Ohtani, N.1
Kida, K.2
Shoji, K.3
Yasui, Y.4
Masaki, E.5
-
16
-
-
0037686526
-
Effect-site concentration of propofol for recovery of consciousness is virtually independent of fentanyl effect-site concentration
-
Iwakiri H, Nagata O, Matsukawa T, Ozaki M, Sessler DI. Effect-site concentration of propofol for recovery of consciousness is virtually independent of fentanyl effect-site concentration. Anesth Analg 2003; 96: 1651-5.
-
(2003)
Anesth Analg
, vol.96
, pp. 1651-1655
-
-
Iwakiri, H.1
Nagata, O.2
Matsukawa, T.3
Ozaki, M.4
Sessler, D.I.5
-
17
-
-
34250633616
-
Propofol infusion syndrome
-
Kam PC, Cardone D. Propofol infusion syndrome. Anaesthesia 2007; 62: 690-701.
-
(2007)
Anaesthesia
, vol.62
, pp. 690-701
-
-
Kam, P.C.1
Cardone, D.2
-
18
-
-
3242804352
-
Propofol inhibits human platelet aggregation induced by proinflammatory lipid mediators
-
Fourcade O, Simon MF, Litt L, Samii K, Chap H. Propofol inhibits human platelet aggregation induced by proinflammatory lipid mediators. Anesth Analg 2004; 99: 393-8.
-
(2004)
Anesth Analg
, vol.99
, pp. 393-398
-
-
Fourcade, O.1
Simon, M.F.2
Litt, L.3
Samii, K.4
Chap, H.5
-
19
-
-
0031892619
-
In vivo and in vitro studies of the inhibitory effect of propofol on human platelet aggregation
-
Aoki H, Mizobe T, Nozuchi S, Hiramatsu N. In vivo and in vitro studies of the inhibitory effect of propofol on human platelet aggregation. Anesthesiology 1998; 88: 362-70.
-
(1998)
Anesthesiology
, vol.88
, pp. 362-370
-
-
Aoki, H.1
Mizobe, T.2
Nozuchi, S.3
Hiramatsu, N.4
-
20
-
-
0030968628
-
Propofol inhibits in vitro platelet aggregation in human whole blood
-
De La Cruz JP, Carmona JA, Paez MV, Blanco E, Sanchez De La Cuesta F. Propofol inhibits in vitro platelet aggregation in human whole blood. Anesth Analg 1997; 84: 919-21.
-
(1997)
Anesth Analg
, vol.84
, pp. 919-921
-
-
de la Cruz, J.P.1
Carmona, J.A.2
Paez, M.V.3
Blanco, E.4
de la Cuesta Sanchez, F.5
-
21
-
-
3042598510
-
Metabolic acidosis associated with propofol in the absence of other causative factors
-
Burow BK, Johnson ME, Packer DL. Metabolic acidosis associated with propofol in the absence of other causative factors. Anesthesiology 2004; 101: 239-41.
-
(2004)
Anesthesiology
, vol.101
, pp. 239-241
-
-
Burow, B.K.1
Johnson, M.E.2
Packer, D.L.3
-
22
-
-
19044363328
-
Propofol infusion syndrome associated with short-term large-dose infusion during surgical anesthesia in an adult
-
Liolios A, Guerit JM, Scholtes JL, Raftopoulos C, Hantson P. Propofol infusion syndrome associated with short-term large-dose infusion during surgical anesthesia in an adult. Anesth Analg 2005; 100: 1804-6.
-
(2005)
Anesth Analg
, vol.100
, pp. 1804-1806
-
-
Liolios, A.1
Guerit, J.M.2
Scholtes, J.L.3
Raftopoulos, C.4
Hantson, P.5
-
23
-
-
33750086060
-
Propofol infusion syndrome--a fatal case at a low infusion rate
-
Merz TM, Regli B, Rothen HU, Felleiter P. Propofol infusion syndrome--a fatal case at a low infusion rate. Anesth Analg 2006; 103: 1050.
-
(2006)
Anesth Analg
, vol.103
, pp. 1050
-
-
Merz, T.M.1
Regli, B.2
Rothen, H.U.3
Felleiter, P.4
-
24
-
-
3042693387
-
Lactic acidosis during propofol-remifentanil anesthesia in an adult
-
Salengros JC, Velghe-Lenelle CE, Bollens R, Engelman E, Barvais L. Lactic acidosis during propofol-remifentanil anesthesia in an adult. Anesthesiology 2004; 101: 241-3.
-
(2004)
Anesthesiology
, vol.101
, pp. 241-243
-
-
Salengros, J.C.1
Velghe-Lenelle, C.E.2
Bollens, R.3
Engelman, E.4
Barvais, L.5
-
25
-
-
0029739504
-
Cardiovascular regulation in mice lacking alpha2-adrenergic receptor subtypes b and c
-
Link RE, Desai K, Hein L, Stevens ME, Chruscinski A, Bernstein D, et al. Cardiovascular regulation in mice lacking alpha2-adrenergic receptor subtypes b and c. Science 1996; 273: 803-5.
-
(1996)
Science
, vol.273
, pp. 803-805
-
-
Link, R.E.1
Desai, K.2
Hein, L.3
Stevens, M.E.4
Chruscinski, A.5
Bernstein, D.6
-
26
-
-
0023628340
-
Cloning, sequencing, and expression of the gene coding for the human platelet alpha 2-adrenergic receptor
-
Kobilka BK, Matsui H, Kobilka TS, Yang-Feng TL, Francke U, Caron MG, et al. Cloning, sequencing, and expression of the gene coding for the human platelet alpha 2-adrenergic receptor. Science 1987; 238: 650-6.
-
(1987)
Science
, vol.238
, pp. 650-656
-
-
Kobilka, B.K.1
Matsui, H.2
Kobilka, T.S.3
Yang-Feng, T.L.4
Francke, U.5
Caron, M.G.6
-
27
-
-
1842283729
-
Cloning and expression of a human kidney cDNA for an alpha 2-adrenergic receptor subtype
-
Regan JW, Kobilka TS, Yang-Feng TL, Caron MG, Lefkowitz RJ, Kobilka BK. Cloning and expression of a human kidney cDNA for an alpha 2-adrenergic receptor subtype. Proc Natl Acad Sci U S A 1988; 85: 6301-5.
-
(1988)
Proc Natl Acad Sci U S A
, vol.85
, pp. 6301-6305
-
-
Regan, J.W.1
Kobilka, T.S.2
Yang-Feng, T.L.3
Caron, M.G.4
Lefkowitz, R.J.5
Kobilka, B.K.6
-
28
-
-
33750464516
-
Effects of low and high plasma concentrations of dexmedetomidine on myocardial perfusion and cardiac function in healthy male subjects
-
quiz 1069-70
-
Snapir A, Posti J, Kentala E, Koskenvuo J, Sundell J, Tuunanen H, et al. Effects of low and high plasma concentrations of dexmedetomidine on myocardial perfusion and cardiac function in healthy male subjects. Anesthesiology 2006; 105: 902-10; quiz 1069-70.
-
(2006)
Anesthesiology
, vol.105
, pp. 902-910
-
-
Snapir, A.1
Posti, J.2
Kentala, E.3
Koskenvuo, J.4
Sundell, J.5
Tuunanen, H.6
-
29
-
-
0030610424
-
Substitution of a mutant alpha2a-adrenergic receptor via "hit and run" gene targeting reveals the role of this subtype in sedative, analgesic, and anesthetic-sparing responses in vivo
-
Lakhlani PP, McMillan LB, Guo TZ, McCool BA, Lovinger DM, Maze M, et al. Substitution of a mutant alpha2a-adrenergic receptor via "hit and run" gene targeting reveals the role of this subtype in sedative, analgesic, and anesthetic-sparing responses in vivo. Proc Natl Acad Sci U S A 1997; 94: 9950-5.
-
(1997)
Proc Natl Acad Sci U S A
, vol.94
, pp. 9950-9955
-
-
Lakhlani, P.P.1
MacMillan, L.B.2
Guo, T.Z.3
McCool, B.A.4
Lovinger, D.M.5
Maze, M.6
|